However, to the best of our knowledge, ours is the first study assessing the potential contribution of a set of single nucleotide polymorphisms in the vWF and ADAMTS13 genes, key factors in the background of CAC, to increased thrombotic risk among COVID-19 patients. The gene discussed is ADAMTS13; the disease is COVID-19.